Scott Warchal

The Francis Crick Institute — United Kingdom

Medicine · Health Sciences

8h-index1.0kcitations15works3.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(13), COVID-19 Clinical Research Studies(10), Vaccine Coverage and Hesitancy(4), COVID-19 epidemiological studies(2), Animal Virus Infections Studies(2)

Publications15 total

Third exposure to COVID-19 infection or vaccination differentially impacts T cell responses
Journal of Infection·2025Open Access
Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling study
The Lancet Infectious Diseases·2024· 6 citedOpen Access
Antibacterial activity of Au(I), Pt(II), and Ir(III) biotin conjugates prepared by the iClick reaction: influence of the metal coordination sphere on the biological activity
JBIC Journal of Biological Inorganic Chemistry·2024· 5 citedOpen Access
Spherical Phenotype Clustering
2024· 1 citedOpen Access
SARS-CoV-2 mucosal neutralising immunity after vaccination
The Lancet Infectious Diseases·2023· 8 citedOpen Access
33 Fourth dose bivalent mRNA vaccines containing BA.1 significantly augment neutralising antibody titres against SARS-COV-2 Omicron sub-lineages XBB and BQ.1.1 in healthy adults
Clinical Infection in Practice·2023Open Access
Neutralising immunity to omicron sublineages BQ.1.1, XBB, and XBB.1.5 in healthy adults is boosted by bivalent BA.1-containing mRNA vaccination and previous Omicron infection
The Lancet Infectious Diseases·2023· 32 citedOpen Access
Strong peak immunogenicity but rapid antibody waning following third vaccine dose in older residents of care homes
Nature Aging·2023· 25 citedOpen Access
Three-dose vaccination elicits neutralising antibodies against omicron
The Lancet·2022· 99 citedOpen Access
Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients
The Lancet·2021· 91 citedOpen Access
Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains
eLife·2021· 51 citedOpen Access
Author response: Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains
2021· 1 citedOpen Access
AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC
The Lancet·2021· 134 citedOpen Access
Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination
The Lancet·2021· 556 citedOpen Access
Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains
2021· 22 citedOpen Access

Frequent Co-authors

Mary Wu(20), Ruth Harvey(15), Charles Swanton(13), Sonia Gandhi(13), Rupert Beale(12), David L.V. Bauer(12), George Kassiotis(11), Karen Ambrose(10), Emma Wall(9), Gavin Kelly(9), Steve Gamblin(9), Michael Howell(9), Chelsea Sawyer(8), Vincenzo Libri(8), Bryan Williams(8), Lorin Adams(8), Edward J Carr(8), Murad Miah(7), Mauro Miranda(7), Nicola O’Reilly(7)